Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Comparison of Titanium and Carbon Fiber-Reinforced Polyetheretherketone Spinal Implants in Postoperative Spine Stereotactic Body Radiation Therapy: A Comprehensive Review of Current Evidence and Future Perspectives.

Created on 11 Aug 2026

Authors

Yuhi Suda, Yujiro Nakajima, Kei Ito, Shota Watanabe, Kentaro Taguchi, Satoshi Kito

Published in

Advances in radiation oncology. Volume 11. Issue 11. Pages 102136. Epub Jul 04, 2026.

Abstract

Postoperative stereotactic body radiation therapy (SBRT) for spinal metastases presents technical challenges, particularly in the presence of internal fixation devices. Titanium implants-the standard implant material-cause substantial imaging artifacts in computed tomography (CT) and magnetic resonance (MR) scans, which can lead to target and organ-at-risk contouring problems and compromise the accuracy of dose calculations. Meanwhile, carbon fiber-reinforced polyetheretherketone (Carbon/PEEK) implants have emerged as radiolucent alternatives with favorable imaging properties. This review summarizes the current evidence comparing titanium and Carbon/PEEK implants in the context of postoperative spine SBRT, focusing on differences in artifact size in CT and MR imaging, contouring accuracy, dose perturbation, dose calculation accuracy, image guided radiation therapy, radiation therapy robustness to setup error, and clinical outcomes in photon and proton therapies.

PMID:
42576993
Bibliographic data and abstract were imported from PubMed on 11 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement